Forrester Research reported Q3 2026 total revenues of $86.1 million and a GAAP net loss of $4.4 million. Despite the revenue decline, the company raised the low end of its full-year adjusted EPS guidance to $0.77-$0.82, citing business stabilization and new AI product launches.
Term
Q3 2026
“We continue to see stabilization of the business, with results above consensus, a strong stock buyback program, and prudent expense management. As a result, we are raising the low end of our guidance for 2026 earnings per share.”
George F. Colony, CEO and Chairman
“Our AI focus is deliberate and intentional, and we continue to advance our product roadmap, delivering new AI capabilities. This quarter, we unveiled a robust portfolio of new products including AI Access Plus, Team Solutions, and an integration with Claude.”
Columbia Sportswear reported Q3 2026 net sales of $962.6 million, a 2% increase year-over-year, and diluted EPS of $1.66. The company raised the low end of its full-year 2026 revenue and EPS guidance, citing improved trends in U.S. direct-to-consumer business and international momentum.
Term
Q3 2026
“We’re pleased to have delivered net sales and EPS growth exceeding our guidance for the third quarter. These results primarily reflected a portion of delayed Fall ’26 wholesale orders shipping earlier-than-expected, improved trends in our U.S. DTC business, and the continued momentum of our international business, despite challenging global macroeconomic conditions.”
Tim Boyle, Chairman and Chief Executive Officer
“While fourth quarter execution will be critical to our full year performance, better-than-expected third quarter performance combined with improving trends in our U.S. business and the shipment of remaining Fall ’26 global wholesale orders gives us the confidence to raise the low end of our full-year revenue and EPS guidance.”
Gen Digital Inc. reported net revenues of $1,369 million for the quarter ended October 2, 2026, up from $1,220 million in the prior year period. Net income significantly increased to $287 million compared to $134 million, driven by higher gross profits and lower interest expenses.
Middlesex Water Co reported a significant increase in net income for the nine months ended September 30, 2026, reaching $43.4 million compared to $34.2 million in the prior year period. Operating revenues grew by 11.9% year-over-year, driven by higher operating income, while the company continued to expand its utility plant assets to over $1.5 billion.
Biohaven Ltd. reported third quarter 2026 financial results and provided updates on its clinical pipeline, including the FDA's acceptance of the NDA resubmission for troriluzole. The company highlighted significant regional licensing deals with SK Biopharmaceuticals and Ono Pharmaceutical, which are expected to provide substantial near-term cash consideration.
“This quarter marked important progress in executing our strategy of building differentiated platforms and partnering them to create both near-term and long-term value. We are excited to have entered into the first ever regional collaboration for an extracellular protein degrader with Ono Pharmaceutical to develop and commercialize our MoDE IgG degrader portfolio, led by BHV-1300, in Japan, South Korea, Taiwan and the ASEAN region.”
Vlad Coric, M.D., Chairman and Chief Executive Officer of Biohaven
“Establishing these unique collaborations with two leading global drug development and commercialization companies is a testament to the impressive potential and versatility of our portfolio.”
Vlad Coric, M.D., Chairman and Chief Executive Officer of Biohaven
Ecolab Inc. reported net sales of $4.69 billion for the third quarter of 2026, an increase from $4.17 billion in the prior year, though net income attributable to Ecolab decreased slightly to $551.3 million. The company's balance sheet showed significant growth in total assets to $31.1 billion, primarily driven by a substantial increase in goodwill and intangible assets following $4.68 billion in acquisition activity during the first nine months of the year.
CareDx reported a significant increase in total revenue to $389.0 million for the nine months ended September 30, 2026, compared to $271.4 million in the prior year. The company achieved a net income of $132.7 million during this period, primarily driven by a $113.0 million gain from the sale of its lab products business and strong growth in testing services revenue.
Pro-Dex, Inc. reported its fiscal 2027 first quarter results, with net sales increasing 11% to $20.6 million driven by medical device revenue growth. Net income decreased to $3.0 million from $4.7 million in the prior year, primarily due to a significant decrease in unrealized gains on marketable equity investments compared to the year-ago period.
Term
Q1 2027
“We are pleased with our first quarter results and continued top line revenue growth.”
Richard L. (“Rick”) Van Kirk, the Company’s President and Chief Executive Officer
“We are also pleased to be working with the Monogram and Zimmer Biomet teams and expect to ship validation units later this fiscal year.”
Richard L. (“Rick”) Van Kirk, the Company’s President and Chief Executive Officer
Biohaven Ltd. reported a net loss of $129.3 million for the third quarter of 2026, an improvement from the $173.4 million loss in the prior year period. The company continues to fund its clinical pipeline in immunology, obesity, and neuroscience, ending the period with $161.1 million in cash and marketable securities.
Gilead Sciences reported third-quarter 2026 financial results, featuring a 13% increase in total product sales to $8.3 billion, driven by strong performance in its HIV portfolio. The company raised its full-year base business revenue guidance for the second time this year, citing robust demand for Biktarvy and HIV prevention products.
“Gilead delivered an exceptional third quarter, with our strongest year-over-year base business growth in more than a decade, reflecting the strength, breadth and durability of our business.”
Daniel O’Day, Gilead’s Chairman and Chief Executive Officer
“Our performance enabled us to raise our full year base business revenue guidance again this quarter, bringing the total increase to $1.6 billion since the start of 2026.”
Daniel O’Day, Gilead’s Chairman and Chief Executive Officer
Credit Acceptance Corp reported a net loss of $56.6 million for the third quarter of 2026, driven by a significant increase in the provision for credit losses to $410.9 million. Despite a slight increase in total revenue to $594.6 million, the company's nine-month net income fell to $215.1 million compared to $301.9 million in the prior year period.
Northern Trust reported a 40% increase in net income to $642.9 million for the third quarter of 2026, driven by favorable market conditions and higher net interest income. Total revenue grew 13% year-over-year, supported by a $34.0 million gain from the sale of the guardianship service business and gains related to the Visa Exchange Offer.
Dexcom reported Q3 2026 revenue of $1.34 billion, representing 11% year-over-year growth, and raised its full-year 2026 revenue guidance to $5.20-$5.25 billion. Alongside the results, the company announced that its Board of Directors authorized a new $1.0 billion share repurchase program effective through December 31, 2027.
“This quarter, we continued to build momentum across the business, delivering strong revenue growth and margin progression, strengthening our clinical evidence, and advancing key product and operational initiatives. This performance enabled us to again raise our full-year revenue and operating margin guidance and reinforces our confidence in our ability to deliver on the long-term objectives we outlined at Investor Day.”
Strategy Inc reported record Q3 2026 operating income of $21 billion and diluted EPS of $44.75, driven by a $20.91 billion gain on its digital assets. The company also announced a CFO transition, with Andrew Kang resigning effective November 5, 2026, to be succeeded by Reza Virasteh on January 1, 2027.
Term
Q3 2026
“Strategy demonstrated its commitment to returning STRC to health. We grew our USD Assets to $5.1 billion, increased USD Duration to 3.4 years, and repurchased $2.0 billion of STRC. We also continued to innovate. With shareholder approval on October 28, we upgraded STRF, STRC, STRK, and STRD to daily dividends, so investors can accrue dividends every calendar day of the year, including weekends and holidays. Daily dividends are a natural step toward the tokenized, 24/7/365 financial system. Digital Credit is being built for that world, and Strategy intends to lead it,”
Phong Le, President and Chief Executive Officer
“Q3 operating income of $21 billion was the largest ever in Strategy’s history. We've also raised $21 billion of equity capital and increased our bitcoin holdings by 26% year-to-date in a challenging bitcoin market. Lastly, it has been an honor and privilege to serve as Strategy’s CFO for the past four and a half years, and I am grateful for the support of Michael, Phong, the Board, our employees and our shareholders through the tremendous growth over that period,”
OneSpan Inc. reported third quarter 2026 revenue of $63.9 million, a 12% year-over-year increase driven by strong subscription growth. The company raised its full-year 2026 revenue and Adjusted EBITDA guidance while declaring a quarterly cash dividend of $0.13 per share.
Term
Q3 2026
“We delivered an excellent third quarter, highlighted by 16% subscription revenue growth and a 12% increase in operating income. We have continued to improve our execution in both our Cybersecurity business and our Digital Agreements business; we are doing so while also investing to strengthen our competitive position and support longer-term growth.”
First Solar reported Q3 2026 net sales of $1.23 billion and net income of $5.30 per diluted share, while lowering its full-year volume and sales guidance. The company's board also authorized a new $500 million share repurchase program with no expiration date.
“Section 232 represents a structural change in how the United States approaches solar manufacturing. As a technology company and the only fully-integrated utility-scale solar manufacturer without dependency on the Chinese crystalline silicon supply chain, we believe we are structurally positioned to benefit from this environment.”
Incyte Corporation reported total revenues of $4.5 billion for the nine months ended September 30, 2026, a significant increase from $3.6 billion in the prior year. However, the company recorded a net loss of $784.8 million for the third quarter of 2026, primarily driven by a substantial increase in research and development expenses to $1.79 billion.
Middlesex Water Company reported Q3 2026 net income of $18.0 million, up from $14.0 million in the prior year, driven by increased wholesale demand and higher customer consumption. The company also declared a 5.56% increase in its quarterly cash dividend to $0.38 per share and invested $84 million in infrastructure year-to-date.
Term
Q3 2026
“Our strong third-quarter results reflect increased wholesale demand, higher customer consumption, and the continued execution of our regulatory strategy. As we deliver solid earnings growth, we remain focused on investing in critical water and wastewater infrastructure, strengthening system reliability, and pursuing selective and sustainable growth under our MWC 2030 Vision to create long-term value for customers and shareholders.”
Nadine Leslie, Chair, President, and Chief Executive Officer
BridgeBio Pharma reported Q3 2026 financial results, highlighted by $353.2 million in total revenue, including $253.2 million from U.S. Attruby net product sales. The company is preparing for three potential product launches in 2026 and 2027 for BBP-418, oral infigratinib, and encaleret, all of which have been granted Priority Review by the FDA.
MVB Financial Corp. reported third quarter 2026 net income of $0.4 million, significantly impacted by a $9.9 million provision for credit losses primarily tied to a single land loan. Despite the credit provision, the company saw positive trends in its fintech business, with Fintech Payments deposits increasing 28.1% sequentially to $766.0 million and core net interest margin expanding 15 basis points to 4.02%.
Term
Q3 2026
“During the third quarter, we made tangible progress on several key initiatives that are strengthening our underlying business. Net interest income has increased 18% through the first nine months of the year, while core net interest margin expanded 15 basis points during the quarter to 4.02%.”
Larry F. Mazza, President and Chief Executive Officer
“We also took decisive action during the quarter to address specific credit exposures, resulting in an elevated provision for credit losses that had a significant impact on earnings. Nearly three quarters of the increase in nonperforming loans and almost half of the provision were attributable to one land loan involving borrower- and property-specific circumstances.”
Larry F. Mazza, President and Chief Executive Officer
Credit Acceptance Corp reported a consolidated net loss of $56.6 million for Q3 2026, primarily due to a $291.2 million decline in forecasted net cash flows following a methodology adjustment. Despite the net loss, the company saw record consumer loan assignment volume of $1.4 billion (up 51% YoY) and reached an all-time high of 12,093 active dealers.
Term
Q3 2026
“During the third quarter, Consumer Loan unit and dollar volume grew 38% and 51%, respectively, both economic profit and adjusted net income experienced double-digit growth, and the number of active dealers reached an all-time high. One of the most encouraging aspects of this growth is that rather than relying on a single lever, our momentum is driven by our four-pronged strategy of customer obsession, segmentation, leveraging data and AI, and disciplined operating rhythms and practices. We believe execution of this strategy strengthens our forecasting, pricing, and operating processes and positions the Company to make more informed capital-allocation decisions.”
CareDx reported third quarter 2026 revenue of $139 million, a 39% year-over-year increase driven by strong growth in Testing Services. The company achieved GAAP net income of $19 million and raised its full-year 2026 revenue guidance to a range of $520 million to $530 million.
“We delivered another strong quarter of solid execution, with continued growth in Transplant, progress scaling Specialty Oncology, and important advances across our pipeline and clinical evidence, including in Cell Therapy.”
John Hanna, President and Chief Executive Officer of CareDx
“We see significant clinical interest in how molecular information can inform more decisions across a patient’s care journey, while continuing to make our solutions easier for providers to adopt and patients to access. We believe these dynamics create meaningful opportunities for continued profitable growth.”
John Hanna, President and Chief Executive Officer of CareDx
OSI Systems reported record fiscal Q1 2027 revenues of $403 million and record GAAP EPS of $1.51, driven by strong performance in its Security and Optoelectronics divisions. The company achieved a record backlog of $2.1 billion and raised its full-year non-GAAP EPS guidance while reaffirming its revenue outlook.
Term
Q1 2027
“We are pleased to begin fiscal 2027 with record first quarter revenues and earnings per share, led by the performance of our Security and Optoelectronics and Manufacturing divisions. Bookings of $583 million represented a book-to-bill ratio of 1.4 in the quarter, and backlog increased to a record of $2.1 billion from $1.9 billion as of June 30, 2026, providing meaningful visibility into future opportunities.”
Ajay Mehra, OSI Systems’ President and Chief Executive Officer
“Operating cash flow more than doubled in the first fiscal quarter over the prior year Q1 to $37 million, and we finished the quarter with approximately $302 million of cash, cash equivalents and short-term investments.”
Alan Edrick, OSI Systems’ Executive Vice President and Chief Financial Officer
For the nine months ended September 30, 2026, Starz Entertainment Corp reported a net loss of $389.1 million on total revenue of $937.2 million, compared to a net loss of $248.1 million in the prior year period. The increased loss was primarily driven by $282.0 million in restructuring and other expenses and higher depreciation and amortization costs.
Rimini Street reported revenue of $112.1 million for the third quarter of 2026, a year-over-year increase from $103.4 million. Net income for the quarter was $6.5 million, up from $2.8 million in the prior year, while the company significantly reduced its total stockholders' deficit to $11.5 million.
For the three months ended September 30, 2026, Pro-Dex reported net sales of $20.6 million, an 11% increase over the prior year, though net income decreased to $3.0 million from $4.7 million due to a significantly smaller unrealized gain on investments. The company maintained a strong balance sheet with $11.8 million in cash and expanded its operations into precision machined parts for the aerospace and defense industries.
SkyWest reported Q3 2026 net income of $120 million on revenue of $1.12 billion, driven by a 5% increase in block hour production. During the quarter, the company took delivery of four new E175 aircraft and repurchased $75 million of its common stock.
Term
Q3 2026
“Our results reflect the value we provide to our customers, including our ongoing opportunities to invest in the fleet. We are well positioned to continue the growth of our E175 fleet in the coming years, enhancing the resiliency of our model for the benefit of our people, our customers and our shareholders. I want to thank our team for their hard work during this busy summer.”
Chip Childs, President and Chief Executive Officer of SkyWest
Starz Entertainment Corp. reported third-quarter 2026 revenue of $322.4 million and an operating loss of $21.2 million. The company reaffirmed its full-year 2026 targets, including mid-single-digit Adjusted OIBDA growth and unlevered free cash flow between $100 million and $120 million.
Term
Q3 2026
“Our third-quarter results reflect the continued strength of the business and our focused execution against our four key financial priorities. Our portfolio approach to programming is driving a more durable revenue base, and we are just beginning to unlock the financial upside of increased ownership. We remain confident in our outlook and in our ability to continue delivering against our plan and create long-term value for our shareholders.”
American Coastal Insurance Corporation reported Q3 2026 net income of $19.4 million and a combined ratio of 64.7%. The company saw a return to year-over-year growth in gross premiums written for the first time since early 2025, despite a softening market with net pricing down over 25%.
Term
Q3 2026
“Our third quarter results reflect the strength of our disciplined underwriting in a softening market. With our net pricing down more than 25% year over year, American Coastal delivered solid results against a very strong prior-year quarter, including net income of $19.4 million, a 64.7% combined ratio and a 24.1% core return on equity.”
B. Bradford Martz, President & Chief Executive Officer
“Just as important, our underlying combined ratio was 68.4% for the quarter, in line with the first two quarters of the year, which tells us the quality of our portfolio has not changed even as rates have come down. We also returned to year-over-year growth in gross premiums written for the first time since early 2025.”
B. Bradford Martz, President & Chief Executive Officer
Alignment Healthcare reported Q3 2026 revenue of $1.36 billion, a 36.7% year-over-year increase, driven by a 31.2% growth in health plan membership to 301,200 members. Despite the revenue growth, the company lowered its full-year 2026 adjusted gross profit and adjusted EBITDA guidance due to higher-than-expected medical trends and costs in catastrophic cases and skilled nursing.
Term
Q3 2026
“Our third-quarter membership and revenue growth demonstrate continued demand for Alignment’s products and services, while medical trends ran higher than expected. We are taking a prudent approach to the fourth quarter and lowering our outlook based on current headwinds.”